Retatrutide 50mg | Triple Receptor Agonist Peptide | For In-Vitro Research Use Only
Retatrutide is a synthetic triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, widely studied in metabolic and cellular receptor research. This 50mg preparation is intended strictly for laboratory and in-vitro research applications.
Product Details
- Compound: Retatrutide (GLP-1/GIP/Glucagon triple agonist)
- Quantity: 50mg
- Purity: Research grade
- Form: Lyophilised powder
- Storage: Store at -20°C, away from light and moisture
For Research Use Only. Not intended for human or veterinary use. Handle in accordance with good laboratory practice.